Howard W. Robin
2008
In 2008, Howard W. Robin earned a total compensation of $2.5M as President and Chief Executive Officer at Nektar Therapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $618,800 |
|---|---|
| Option Awards | $1,192,880 |
| Salary | $680,000 |
| Other | $14,586 |
| Total | $2,506,266 |
Robin received $1.2M in option awards, accounting for 48% of the total pay in 2008.
Robin also received $618.8K in non-equity incentive plan, $680K in salary and $14.6K in other compensation.
Rankings
In 2008, Howard W. Robin's compensation ranked 1,911th out of 9,135 executives tracked by ExecPay. In other words, Robin earned more than 79.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,911 out of 9,135 | 79th |
Division Manufacturing | 682 out of 3,436 | 80th |
Major group Chemicals And Allied Products | 124 out of 815 | 85th |
Industry group Drugs | 76 out of 597 | 87th |
Industry Pharmaceutical Preparations | 59 out of 408 | 86th |
Source: SEC filing on April 29, 2011.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2008.